COMBINATION THERAPY USING PENTAFLUOROBENZENESULFONAMIDE AND PLATIN COMPOUND

(19)

(11)

EP 1 206 256 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	29.06.2005 Bulletin 2005/26

(45)	Mention of the grant of the patent:
	04.05.2005 Bulletin 2005/18

(21)	Application number: 00953755.6

(22)	Date of filing: 27.07.2000

(51)	International Patent Classification (IPC)⁷: A61K 31/18, A61K 31/28, A61P 35/00, A61K 31/282

(86)	International application number:
	PCT/US2000/020763

(87)	International publication number:
	WO 2001/008693 (08.02.2001 Gazette 2001/06)

(54)	COMBINATION THERAPY USING PENTAFLUOROBENZENESULFONAMIDE AND PLATIN COMPOUND KOMBINATION THERAPIE MIT PENTAFLUOROBENZENESULFONAMID UND PLATIN-DERIVATE THERAPIE D'ASSOCIATION COMPRENANT L'ADMINISTRATION DE PENTAFLUOROBENZENESULFONAMIDES

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

29.07.1999 US 146436 P

(43)	Date of publication of application:
	22.05.2002 Bulletin 2002/21

(73)	Proprietor: Amgen, Inc.
	Thousands Oaks, CA 91320-1799 (US)

(72)	Inventors:
	SCHWENDNER, Susan San Bruno, CA 94066 (US) TIMMERMANS, Pieter Redwood City, CA 94062 (US) WALLING, Jacqueline Clifton, Bristol, Avon BS8 1PQ (US)

(74)	Representative: Thomson, Paul Anthony et al
	Potts, Kerr & Co., 15, Hamilton Square Birkenhead, Merseyside CH41 6BR Birkenhead, Merseyside CH41 6BR (GB)

(56)

References cited: :

WO-A-00/17159
WO-A-00/73264
WO-A-98/16227
WO-A-99/67258

WO-A-00/35865
WO-A-98/05315
WO-A-98/22101

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).